Iodinated benzimidazole PARP radiotracer for evaluating PARP1/2 expression in vitro and in vivo
Abstract
PARP inhibitors (PARPi) have the potential to impact cancer therapy in a selective patient population; however, despite current patient selection methods clinical trials have shown mixed response rates. It is therefore clinically useful to determine which patients will respond prior to receiving PARPi therapy. One essential biomarker is to measure the level of PARP enzyme expression in tumors. Small molecule radiotracers have been developed to...
Paper Details
Title
Iodinated benzimidazole PARP radiotracer for evaluating PARP1/2 expression in vitro and in vivo
Published Date
Dec 1, 2016
Journal
Volume
43
Issue
12
Pages
752 - 758
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History